Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 101–200 of 1,002
Kornicka, K., Houston, J., & Marycz, K. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9809-x · Cited by 184
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Tiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44564 · Cited by 180
Self-citationSun, J., Cui, J., He, Q., Chen, Z., Arvan, P., & Liu, M. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.01.001 · Cited by 179
Gómez-Banoy, N., Guseh, J. S., Li, G., Rubio-Navarro, A., Chen, T., Poirier, B., Putzel, G., Rosselot, C., Pabón, M. A., Camporez, J. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0610-4 · Cited by 178
Ahima, R. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58719 · Cited by 176
Vendrell, J., El Bekay, R., Peral, B., García-Fuentes, E., Megia, A., Macias-Gonzalez, M., Real, J. F., Jimenez-Gomez, Y., Escoté, X., Pachón, G., et al. (2011) · Endocrinology · doi:10.1210/en.2011-1070 · Cited by 173
Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits
Spijker, H. S., Song, H., Ellenbroek, J. H., Roefs, M. M., Engelse, M. A., Bos, E., Koster, A. J., Rabelink, T. J., Hansen, B. C., Clark, A., et al. (2015) · Diabetes · doi:10.2337/db14-1752 · Cited by 172
“Loss of pancreatic b-cell mass and b-cell dysfunction are central in the development of type 2 diabetes (T2DM) and, in combination with peripheral insulin resistance, lead to hyperglycemia (1).”
MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity
Jacovetti, C., Abderrahmani, A., Parnaud, G., Jonas, J.-C., Peyot, M.-L., Cornu, M., Laybutt, R., Meugnier, E., Rome, S., Thorens, B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64151 · Cited by 171
Self-citationZhang, Z., Wakabayashi, N., Wakabayashi, J., Tamura, Y., Song, W.-J., Sereda, S., Clerc, P., Polster, B. M., Aja, S. M., Pletnikov, M. V., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-12-0933 · Cited by 171
Connexins: Key Mediators of Endocrine Function
Bosco, D., Haefliger, J.-A., & Meda, P. (2011) · Physiological Reviews · doi:10.1152/physrev.00027.2010 · Cited by 169
A causal role for hyperinsulinemia in obesity
Templeman, N. M., Skovsø, S., Page, M. M., Lim, G. E., & Johnson, J. D. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0449 · Cited by 168
The unique hypusine modification of eIF5A promotes islet β cell inflammation and dysfunction in mice
Maier, B., Ogihara, T., Trace, A. P., Tersey, S. A., Robbins, R. D., Chakrabarti, S. K., Nunemaker, C. S., Stull, N. D., Taylor, C. A., Thompson, J. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38924 · Cited by 166
Animal models for type 1 and type 2 diabetes: advantages and limitations
Singh, R., Gholipourmalekabadi, M., & Shafikhani, S. H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359685 · Cited by 163
DNA methylation directs functional maturation of pancreatic β cells
Dhawan, S., Tschen, S.-I., Zeng, C., Guo, T., Hebrok, M., Matveyenko, A., & Bhushan, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79956 · Cited by 164
Matheus, V., Monteiro, L., Oliveira, R., Maschio, D., & Collares-Buzato, C. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708188 · Cited by 165
Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes
Weir, G. C. (2020) · Diabetes · doi:10.2337/db19-0138 · Cited by 164
Tan, C. P., Feng, Y., Zhou, Y.-P., Eiermann, G. J., Petrov, A., Zhou, C., Lin, S., Salituro, G., Meinke, P., Mosley, R., et al. (2008) · Diabetes · doi:10.2337/db08-0130 · Cited by 163
Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis
Jordan, S. D., Könner, A. C., & Brüning, J. C. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0414-7 · Cited by 163
Sturek, J. M., Castle, J. D., Trace, A. P., Page, L. C., Castle, A. M., Evans-Molina, C., Parks, J. S., Mirmira, R. G., & Hedrick, C. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41280 · Cited by 163
Leptin brain entry via a tanycytic LepR–EGFR shuttle controls lipid metabolism and pancreas function
Duquenne, M., Folgueira, C., Bourouh, C., Millet, M., Silva, A., Clasadonte, J., Imbernon, M., Fernandois, D., Martinez-Corral, I., Kusumakshi, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00432-5 · Cited by 161
Ferdaoussi, M., Bergeron, V., Zarrouki, B., Kolic, J., Cantley, J., Fielitz, J., Olson, E. N., Prentki, M., Biden, T., MacDonald, P. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2650-x · Cited by 160
“to secrete an adequate amount of insulin to compensate for peripheral insulin resistance [2].”
BackgroundSelf-citationStress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
Novials, A., Montane, J., & Cadavez-Trigo, L. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s37649 · Cited by 159
Cholesterol in islet dysfunction and type 2 diabetes
Brunham, L. R., Kruit, J. K., Verchere, C. B., & Hayden, M. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33296 · Cited by 158
“Several lines of evidence have been advanced to explain the deterioration in insulin secretory output (5).”
BackgroundSachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 158
Immune Regulation in Obesity-Associated Adipose Inflammation
Han, J. M., & Levings, M. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301035 · Cited by 157
Guay, C., Madiraju, S. R. M., Aumais, A., Joly, É., & Prentki, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707294200 · Cited by 157
Self-citationThe Furan Fatty Acid Metabolite CMPF Is Elevated in Diabetes and Induces β Cell Dysfunction
Prentice, K. J., Luu, L., Allister, E. M., Liu, Y., Jun, L. S., Sloop, K. W., Hardy, A. B., Wei, L., Jia, W., Fantus, I. G., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.008 · Cited by 175
“The underlying cause of both GDM and T2D is a failure of the b cell to respond to changing metabolic demands, namely increased insulin resistance (Buchanan, 2001; Kahn, 2003; Prentki and Nolan, 2006).”
BackgroundFSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults
Mukherjee, A., Sidis, Y., Mahan, A., Raher, M. J., Xia, Y., Rosen, E. D., Bloch, K. D., Thomas, M. K., & Schneyer, A. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607966104 · Cited by 157
Animal models for diabetes: Understanding the pathogenesis and finding new treatments
King, A., & Bowe, J. E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.108 · Cited by 176
The islet β-cell: fuel responsive and vulnerable
Nolan, C. J., & Prentki, M. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.006 · Cited by 188
Self-citationLankatillake, C., Huynh, T. T., & Dias, D. A. (2019) · Plant Methods · doi:10.1186/s13007-019-0487-8 · Cited by 189
Gerst, F., Wagner, R., Kaiser, G., Panse, M., Heni, M., Machann, J., Bongers, M. N., Sartorius, T., Sipos, B., Fend, F., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4385-1 · Cited by 151
Causes and cures for endoplasmic reticulum stress in lipotoxic β ‐cell dysfunction
Cnop, M., Ladrière, L., Igoillo‐Esteve, M., Moura, R. F., & Cunha, D. A. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01279.x · Cited by 150
Boslem, E., MacIntosh, G. L., Preston, A. M., Bartley, C., Busch, A. K., Fuller, M., Laybutt, D. R., Meikle, P. J., & Biden, T. J. (2011) · Biochemical Journal · doi:10.1042/bj20101867 · Cited by 168
Nutrient-Induced Metabolic Stress, Adaptation, Detoxification, and Toxicity in the Pancreatic β-Cell
Prentki, M., Peyot, M., Masiello, P., & Madiraju, S. R. M. (2020) · Diabetes · doi:10.2337/dbi19-0014 · Cited by 176
“They cannot protect themselves by reducing glucose entry, and they have limited capacity to store excess fuels (2,3,57).”
BackgroundSelf-citationFujita, Y., & Inagaki, N. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12214 · Cited by 148
Evans-Molina, C., Robbins, R. D., Kono, T., Tersey, S. A., Vestermark, G. L., Nunemaker, C. S., Garmey, J. C., Deering, T. G., Keller, S. R., Maier, B., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01179-08 · Cited by 148
Leung, P. S. (2016) · Nutrients · doi:10.3390/nu8030147 · Cited by 165
“T2DM, which is defined as hyperglycemia of sufficient magnitude to cause detrimental effects, results when insulin resistance develops and is followed by dysregulation of insulin secretory responses, with loss of beta-cell mass [29].”
BackgroundReduced Circulating Insulin Enhances Insulin Sensitivity in Old Mice and Extends Lifespan
Templeman, N. M., Flibotte, S., Chik, J. H. L., Sinha, S., Lim, G. E., Foster, L. J., Nislow, C., & Johnson, J. D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.048 · Cited by 148
Peyot, M.-L., Pepin, E., Lamontagne, J., Latour, M. G., Zarrouki, B., Lussier, R., Pineda, M., Jetton, T. L., Madiraju, S. R. M., Joly, E., et al. (2010) · Diabetes · doi:10.2337/db09-1452 · Cited by 147
Self-citationInhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
Mußmann, R., Geese, M., Harder, F., Kegel, S., Andag, U., Lomow, A., Burk, U., Onichtchouk, D., Dohrmann, C. E., & Austen, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609637200 · Cited by 161
Cornu, M., Yang, J.-Y., Jaccard, E., Poussin, C., Widmann, C., & Thorens, B. (2009) · Diabetes · doi:10.2337/db09-0063 · Cited by 146
β-Cell Mass and Type 1 Diabetes
Akirav, E., Kushner, J. A., & Herold, K. C. (2008) · Diabetes · doi:10.2337/db07-1817 · Cited by 146
Pancreatic β cell identity requires continual repression of non–β cell programs
Gutiérrez, G. D., Bender, A. S., Cirulli, V., Mastracci, T. L., Kelly, S. M., Tsirigos, A., Kaestner, K. H., & Sussel, L. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88017 · Cited by 146
Neural regulation of pancreatic islet cell mass and function
Thorens, B. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12346 · Cited by 140
“This bihormonal control of glucose homeostasis is impaired in type 2 diabetes with insufficient insulin secretion capacity to compensate for the development of insulin resistance in peripheral tissues, liver, muscle and fat [1].”
BackgroundCellular communication and heterogeneity in pancreatic islet insulin secretion dynamics
Benninger, R. K. P., & Piston, D. W. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.02.005 · Cited by 145
Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity
Yamamoto, S., Kuramoto, K., Wang, N., Situ, X., Priyadarshini, M., Zhang, W., Cordoba-Chacon, J., Layden, B. T., & He, C. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.032 · Cited by 144
“In DM, type 2 diabetes (T2D), often accompanied by obesity, represents 85%–95% of the total cases (NCD Risk Factor Collaboration, 2016; Kahn et al., 2006; Prentki and Nolan, 2006).”
Wang, S., Yan, J., Anderson, D. A., Xu, Y., Kanal, M. C., Cao, Z., Wright, C. V. E., & Gu, G. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2009.12.009 · Cited by 143
Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents
Gallwitz, B. (2011) · Drugs · doi:10.2165/11592810-000000000-00000 · Cited by 142
“This functional loss is characterized by an increasing defect in the insulin response to glucose as well as a loss of b-cell mass over time.([7,8])”
Age-Related Impairment of Pancreatic Beta-Cell Function: Pathophysiological and Cellular Mechanisms
De Tata, V. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00138 · Cited by 142
“Consequently, beta-cell dysfunction is increasingly recognized to play a fundamental role in type 2 diabetes pathophysiology (48, 49) and could represent another significant contributing factor to abnormal glucose metabolism with age (9, 50).”
BackgroundVilas‐Boas, E. A., de Almeida, D. C., Roma, L. P., Ortis, F., & Carpinelli, Â. R. (2021) · Cells · doi:10.3390/cells10123328 · Cited by 183
“Under this framework, insulin resistance would be compensated by increased β-cell function—termed “glucolipoadaptation” by Prentki and Nolan [57]—to maintain normoglycemia [55].”
BackgroundThe Fractalkine/CX3CR1 System Regulates β Cell Function and Insulin Secretion
Lee, Y. S., Morinaga, H., Kim, J. J., Lagakos, W., Taylor, S., Keshwani, M., Perkins, G., Dong, H., Kayali, A. G., Sweet, I. R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.001 · Cited by 141
Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2288-0 · Cited by 140
“Glucolipotoxicity, which results from elevated circulating levels of glucose and NEFA such as palmitate, can also lead to suppression of islet insulin secretion [26–28], in part through induction of Il1b expression [5, 6, 29].”
BackgroundCauchi, S., Nead, K. T., Choquet, H., Horber, F., Potoczna, N., Balkau, B., Marre, M., Charpentier, G., Froguel, P., & Meyre, D. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-45 · Cited by 140
Kamalden, T. A., Macgregor-Das, A. M., Kannan, S. M., Dunkerly-Eyring, B., Khaliddin, N., Xu, Z., Fusco, A. P., Yazib, S. A., Chow, R. C., Duh, E. J., et al. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6844 · Cited by 138
“As pancreatic b -cells, the only source of insulin, become injured due to chronic metabolic stress such as obesity, insulin production by pancreatic b -cells eventually progressively decreases (37).”
Insulin post-transcriptionally modulates Bmal1 protein to affect the hepatic circadian clock
Dang, F., Sun, X., Ma, X., Wu, R., Zhang, D., Chen, Y., Xu, Q., Wu, Y., & Liu, Y. (2016) · Nature Communications · doi:10.1038/ncomms12696 · Cited by 139
Early neglect and abuse predict diurnal cortisol patterns in adults
van der Vegt, E. J. M., van der Ende, J., Kirschbaum, C., Verhulst, F. C., & Tiemeier, H. W. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.11.004 · Cited by 171
Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes
Moin, A. S. M., & Butler, A. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1194-6 · Cited by 147
Lee, J., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094843 · Cited by 178
“Compensatory processes include the expansion of the mass of β-cells, enhanced insulin biosynthesis, and increased insulin secretion in response to nutrients [54].”
BackgroundKaku, K., Inoue, S., Matsuoka, O., Kiyosue, A., Azuma, H., Hayashi, N., Tokudome, T., Langkilde, A. M., & Parikh, S. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12047 · Cited by 136
Wang, Z., Oh, E., Clapp, D. W., Chernoff, J., & Thurmond, D. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291500 · Cited by 134
Minireview: Estrogenic Protection of β-Cell Failure in Metabolic Diseases
Liu, S., & Mauvais-Jarvis, F. (2010) · Endocrinology · doi:10.1210/en.2009-1107 · Cited by 134
Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it?
Nolan, C. J., & Larter, C. Z. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05823.x · Cited by 134
Altered Islet Composition and Disproportionate Loss of Large Islets in Patients with Type 2 Diabetes
Kilimnik, G., Zhao, B., Jo, J., Periwal, V., Witkowski, P., Misawa, R., & Hara, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027445 · Cited by 132
Zhao, Z., Zhao, C., Zhang, X. H., Zheng, F., Cai, W., Vlassara, H., & Ma, Z. A. (2009) · Endocrinology · doi:10.1210/en.2008-1342 · Cited by 132
Optical control of insulin release using a photoswitchable sulfonylurea
Broichhagen, J., Schönberger, M., Cork, S. C., Frank, J. A., Marchetti, P., Bugliani, M., Shapiro, A. M. J., Trapp, S., Rutter, G. A., Hodson, D. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6116 · Cited by 145
Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?
Othman, A., Rütti, M. F., Ernst, D., Saely, C. H., Rein, P., Drexel, H., Porretta‐Serapiglia, C., Lauria, G., Bianchi, R., von Eckardstein, A., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2384-1 · Cited by 141
Genetic and epigenetic control of metabolic health
Schwenk, R. W., Vogel, H., & Schürmann, A. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.002 · Cited by 153
“However, in a subgroup of patients an exhaustion of beta-cells occurs more rapidly, resulting in insufficient insulin responses to nutrient influx and further aggravation of hyperglycemia as well as hyperlipidemia, leading to accelerated beta-cell destruction [15,16].”
BackgroundBhatt, M. P., Lim, Y.-C., Hwang, J., Na, S., Kim, Y.-M., & Ha, K.-S. (2013) · Diabetes · doi:10.2337/db12-0293 · Cited by 132
Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes
Wang, M., Song, L., Strange, C., Dong, X., & Wang, H. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.013 · Cited by 160
Diabetes and Sepsis: Risk, Recurrence, and Ruination
Frydrych, L. M., Fattahi, F., He, K., Ward, P. A., & Delano, M. J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00271 · Cited by 158
“The contribution of each of these mechanisms remains unclear, but, interestingly, all of these cellular stresses can be caused by over-nutrition (71) and are induced or exacerbated by an inflammatory response (72).”
BackgroundDeoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells
Zuellig, R. A., Hornemann, T., Othman, A., Hehl, A. B., Bode, H., Güntert, T., Ogunshola, O. O., Saponara, E., Grabliauskaite, K., Jang, J.-H., et al. (2014) · Diabetes · doi:10.2337/db13-1042 · Cited by 130
“This remarkable increase is largely due to the epidemic spread of type 2 diabetes (T2DM), which accounts for 90% of all cases of diabetes worldwide (3,4).”
BackgroundJiménez-Lucena, R., Camargo, A., Alcala-Diaz, J. F., Romero-Baldonado, C., Luque, R. M., van Ommen, B., Delgado‐Lista, J., Ordovás, J. M., Pérez‐Martínez, P., Rangel-Zúñiga, O. A., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0194-y · Cited by 147
Pancreatic β-cell identity in diabetes
Remedi, M. S., & Emfinger, C. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12727 · Cited by 128
Palmitate Activates Autophagy in INS-1E β-Cells and in Isolated Rat and Human Pancreatic Islets
Martino, L., Masini, M., Novelli, M., Beffy, P., Bugliani, M., Marselli, L., Masiello, P., Marchetti, P., & Tata, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036188 · Cited by 143
An overview of pancreatic beta-cell defects in human type 2 diabetes: Implications for treatment
Marchetti, P., Dotta, F., Lauro, D., & Purrello, F. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.017 · Cited by 157
Chronic activation of a designer Gq-coupled receptor improves β cell function
Jain, S., de Azua, I. R., Lu, H., White, M. F., Guettier, J.-M., & Wess, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66432 · Cited by 123
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
Tang, W. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.11.003 · Cited by 135
Chan, J. Y., Luzuriaga, J., Bensellam, M., Biden, T. J., & Laybutt, D. R. (2013) · Diabetes · doi:10.2337/db12-0701 · Cited by 123
“both increased b-cell mass and enhanced insulin secretion per b-cell (2,3).”
BackgroundLatreille, M., Herrmanns, K., Renwick, N., Tuschl, T., Malecki, M. T., McCarthy, M. I., Owen, K. R., Rülicke, T., & Stoffel, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1296-9 · Cited by 122
McKenzie, M. D., Jamieson, E. L., Jansen, E. S., Scott, C. L., Huang, D. C. S., Bouillet, P., Allison, J., Kay, T. W. H., Strasser, A., & Thomas, H. E. (2009) · Diabetes · doi:10.2337/db09-1151 · Cited by 132
Glucose regulation of islet stress responses and β‐cell failure in type 2 diabetes
Jonas, J. C., Bensellam, M., Duprez, J., Elouil, H., Guiot, Y., & Pascal, S. M. A. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01112.x · Cited by 118
Methyltransferase Set7/9 Maintains Transcription and Euchromatin Structure at Islet-Enriched Genes
Deering, T. G., Ogihara, T., Trace, A. P., Maier, B., & Mirmira, R. G. (2009) · Diabetes · doi:10.2337/db08-1150 · Cited by 116
Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction
Vergeer, M., Brunham, L. R., Koetsveld, J., Kruit, J. K., Verchere, C. B., Kastelein, J. J. P., Hayden, M. R., & Stroes, E. S. G. (2010) · Diabetes Care · doi:10.2337/dc09-1562 · Cited by 118
Caria, A. C. I., Nonaka, C. K. V., Pereira, C. S., Soares, M. B. P., Macambira, S. G., & Souza, B. S. D. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113608 · Cited by 130
van der Schaft, N., Schoufour, J. D., Nano, J., Kiefte-de Jong, J. C., Muka, T., Sijbrands, E. J. G., Ikram, M. A., Franco, O. H., & Voortman, T. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00548-9 · Cited by 116
Endoplasmic reticulum: nutrient sensor in physiology and pathology
Mandl, J., Mészáros, T., Bánhegyi, G., Hunyady, L., & Csala, M. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.01.003 · Cited by 124
Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2
Jansson, D., Ng, A. C.-H., Fu, A., Depatie, C., Al Azzabi, M., & Screaton, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800796105 · Cited by 115
Li, N., Frigerio, F., & Maechler, P. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360930 · Cited by 114
Caton, P., Richardson, S. J., Kieswich, J. E., Bugliani, M., Holland, M. L., Marchetti, P., Morgan, N. G., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2013) · Diabetologia · doi:10.1007/s00125-013-2851-y · Cited by 121
“This leads to hyperglycaemia, glucose intolerance and onset of type 2 diabetes [1–4].”
BackgroundResultSnapin Mediates Incretin Action and Augments Glucose-Dependent Insulin Secretion
Song, W.-J., Seshadri, M., Ashraf, U., Mdluli, T., Mondal, P., Keil, M., Azevedo, M., Kirschner, L. S., Stratakis, C. A., & Hussain, M. A. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.002 · Cited by 114
Iron Regulation of Pancreatic Beta-Cell Functions and Oxidative Stress
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B., & Mandrup-Poulsen, T. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050939 · Cited by 113
Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans
Begovatz, P., Koliaki, C. C., Weber, K. S., Straßburger, K., Nowotny, B., Nowotny, P., Müssig, K., Bunke, J., Pacini, G., Szendrödi, J., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3544-5 · Cited by 128
“Possible underlying mechanisms leading to beta cell dysfunction are abnormal mitochondrial function and oxidative stress, mainly due to glucose toxicity [3, 4] and lipotoxicity, along with elevated concentrations of NEFA [5, 6].”
BackgroundPhosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets
Sacco, F., Seelig, A., Humphrey, S. J., Krahmer, N., Volta, F., Reggio, A., Marchetti, P., Gerdes, J. M., & Mann, M. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.012 · Cited by 116
“Chronic or recurrent exposure of the beta cell leads to elevated levels of glucose and lipids (glucolipotoxicity) or to proinflammatory cytokines that interfere with beta cell function, contributing to their destruction (Prentki and Nolan, 2006).”
Metabolic syndrome in type 2 diabetic patients: a review of current evidence
Regufe, V. M. G., Pinto, C., & Perez, P. M. V. H. C. (2020) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000101 · Cited by 141
“The former will stay normoglycemic and insulin resistant, whilst the latter will definitely lose the capacity of maintaining the glucose homeostasis.(22) The ectopic fat deposition has better prognosis as well as amore important role in the development of IR if compared to deposition and evaluation of visceral fat.”
BackgroundGKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
Matschinsky, F. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.007 · Cited by 124
G protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 118
Steneberg, P., Lindahl, E., Dahl, U., Lidh, E., Straseviciene, J., Backlund, F., Kjellkvist, E., Berggren, E., Lundberg, I., Bergqvist, I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99114 · Cited by 108
Xie, X., Wu, C., Hao, Y., Wang, T., Yang, Y., Cai, P., Zhang, Y., Huang, J., Deng, K., Yan, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1301093 · Cited by 141
“Studies have shown that the dysfunction of b cells is a major determinant of the progression from normal glucose to hyperglycemia, and is also central to the development of T2D (37, 38).”
Background
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.